Literature DB >> 20368366

Anti-leishmanial drug discovery: rising to the challenges of a highly neglected disease.

Elizabeth R Sharlow1, Max Grögl, Jacob Johnson, John S Lazo.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20368366     DOI： 10.1124/mi.10.2.4

Source DB:  PubMed          Journal:  Mol Interv        ISSN： 1534-0384


× No keyword cloud information.
  4 in total

Review 1.  Drug discovery algorithm for cutaneous leishmaniasis.

Authors:  Max Grogl; Mark Hickman; William Ellis; Thomas Hudson; John S Lazo; Elizabeth R Sharlow; Jacob Johnson; Jonathan Berman; Richard J Sciotti
Journal:  Am J Trop Med Hyg       Date:  2013-02       Impact factor: 2.345

2.  Copaiba Oil: An Alternative to Development of New Drugs against Leishmaniasis.

Authors:  Adriana Oliveira Dos Santos; Tânia Ueda-Nakamura; Benedito Prado Dias Filho; Valdir Florêncio da Veiga Junior; Celso Vataru Nakamura
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-12       Impact factor: 2.629

Review 3.  Exploring the role of medicinal plant-based immunomodulators for effective therapy of leishmaniasis.

Authors:  Garima Chouhan; Mohammad Islamuddin; Dinkar Sahal; Farhat Afrin
Journal:  Front Immunol       Date:  2014-05-05       Impact factor: 7.561

Review 4.  Recent Advances in the Discovery of Novel Antiprotozoal Agents.

Authors:  Seong-Min Lee; Min-Sun Kim; Faisal Hayat; Dongyun Shin
Journal:  Molecules       Date:  2019-10-28       Impact factor: 4.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.